Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Neurona Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Lifesciences Conference
By: GlobeNewswire - 07 Feb 2024Back to overview list

SAN FRANCISCO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s chief executive officer, will provide a corporate update at the Oppenheimer 34th Annual Healthcare Lifesciences Conference on Wednesday, February 14 at 2:00 pm ET.

The presentation will be webcast live and may be accessed via a link in the News section of the Neurona website under Events. An archived copy of the webcast will be available on the website for approximately 30 days after the event.

About Neurona Therapeutics
Neurona is focused on developing regenerative cell therapy candidates with single-dose curative potential. Neurona’s investigational allogeneic, off-the-shelf, cell therapy candidates are designed to provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona, visit www.neuronatherapeutics.com.

Investor and Media Contacts:

Sylvia Wheeler
Wheelhouse LSA
swheeler@wheelhouselsa.com

Elizabeth Wolffe, Ph.D.
Wheelhouse LSA
lwolffe@wheelhouselsa.com


Related companies:Neurona Therapeutics Inc.
Copyright 2024 GlobeNewswire Back to overview list
to the top ↑